In various models of cardiac damage, including diabetic cardiomyopathy (Gbr et al. 2021) and sepsis-induced cardiac dysfunction (Peng et al. 2017), the anti-inflammatory impact of PPAR has been mediated by suppressing NF-κB. The gene discussed is NFKB1; the disease is diabetic cardiomyopathy.